POC-34 reference inputs, download revision 1.1, October 5, 2026.
Fixture contents preserve article revision 1 (September 14, 2026).
Synthetic FDA eCTD v3.2.2 procurement exercise. Not scientific evidence.
NOT a valid eCTD package, XML backbone or vendor import format. No vendor run occurred.
Assyro does not currently support eCTD v3.2.2.

1. Preserve the source texts and leading zeroes in CSV sequence identifiers.
2. Agree the product/edition, format, authority, validator and criteria revision.
3. A competent operator must create suitable renditions and an otherwise qualified
   regional baseline, with actual IDs mapped to the supplied reference IDs.
4. Run P01 and retain its output/history evidence before separate negative copies.
5. N01 uses a superseded predecessor. N02 removes actual regional XML from the
   qualified current package (0002/m1/us/us-regional.xml); changing a CSV flag is
   not that test. U01 withholds history 0001 in a separate workspace.
6. Record actual results as not run/unknown until demonstrated. A negative-control
   pass means the defect was identified, not that the faulty package is acceptable.
7. Preserve each run and report. Gateway transmission is outside this exercise.

Full procedure: https://www.assyro.com/blog/ectd-software-proof-of-concept
